Biotechnology in United States
Biotechnology in United States
SUMMARY
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The US biotechnology market had total revenues of $224.8bn in 2019, representing a compound annual growth rate (CAGR) of 9.8% between 2015 and 2019.
- The medical/healthcare segment was the market's most lucrative in 2019, with total revenues of $132.4bn, equivalent to 58.9% of the market's overall value.
- Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their RandD.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts
- What was the size of the United States biotechnology market by value in 2019?
- What will be the size of the United States biotechnology market in 2024?
- What factors are affecting the strength of competition in the United States biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the United States's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any notable product approvals in recent years?
7.4. What has been the rationale behind M&A activity in 2019?
7.5. Do any leading players have notable weaknesses?
7.6. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. Merck & Co., Inc.
8.2. Amgen, Inc.
8.3. Baxter International Inc.
8.4. Biogen, Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any notable product approvals in recent years?
7.4. What has been the rationale behind M&A activity in 2019?
7.5. Do any leading players have notable weaknesses?
7.6. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. Merck & Co., Inc.
8.2. Amgen, Inc.
8.3. Baxter International Inc.
8.4. Biogen, Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: United States biotechnology industry value: $ billion, 2015-19
Table 2: United States biotechnology industry category segmentation: $ billion, 2019
Table 3: United States biotechnology industry geography segmentation: $ billion, 2019
Table 4: United States biotechnology industry value forecast: $ billion, 2019-24
Table 5: Merck & Co., Inc.: key facts
Table 6: Merck & Co., Inc.: Annual Financial Ratios
Table 7: Merck & Co., Inc.: Key Employees
Table 8: Merck & Co., Inc.: Key Employees Continued
Table 9: Amgen, Inc.: key facts
Table 10: Amgen, Inc.: Annual Financial Ratios
Table 11: Amgen, Inc.: Key Employees
Table 12: Amgen, Inc.: Key Employees Continued
Table 13: Baxter International Inc.: key facts
Table 14: Baxter International Inc.: Annual Financial Ratios
Table 15: Baxter International Inc.: Key Employees
Table 16: Baxter International Inc.: Key Employees Continued
Table 17: Biogen, Inc.: key facts
Table 18: Biogen, Inc.: Annual Financial Ratios
Table 19: Biogen, Inc.: Key Employees
Table 20: United States size of population (million), 2015-19
Table 21: United States gdp (constant 2005 prices, $ billion), 2015-19
Table 22: United States gdp (current prices, $ billion), 2015-19
Table 23: United States inflation, 2015-19
Table 24: United States consumer price index (absolute), 2015-19
Table 25: United States exchange rate, 2015-19
Table 1: United States biotechnology industry value: $ billion, 2015-19
Table 2: United States biotechnology industry category segmentation: $ billion, 2019
Table 3: United States biotechnology industry geography segmentation: $ billion, 2019
Table 4: United States biotechnology industry value forecast: $ billion, 2019-24
Table 5: Merck & Co., Inc.: key facts
Table 6: Merck & Co., Inc.: Annual Financial Ratios
Table 7: Merck & Co., Inc.: Key Employees
Table 8: Merck & Co., Inc.: Key Employees Continued
Table 9: Amgen, Inc.: key facts
Table 10: Amgen, Inc.: Annual Financial Ratios
Table 11: Amgen, Inc.: Key Employees
Table 12: Amgen, Inc.: Key Employees Continued
Table 13: Baxter International Inc.: key facts
Table 14: Baxter International Inc.: Annual Financial Ratios
Table 15: Baxter International Inc.: Key Employees
Table 16: Baxter International Inc.: Key Employees Continued
Table 17: Biogen, Inc.: key facts
Table 18: Biogen, Inc.: Annual Financial Ratios
Table 19: Biogen, Inc.: Key Employees
Table 20: United States size of population (million), 2015-19
Table 21: United States gdp (constant 2005 prices, $ billion), 2015-19
Table 22: United States gdp (current prices, $ billion), 2015-19
Table 23: United States inflation, 2015-19
Table 24: United States consumer price index (absolute), 2015-19
Table 25: United States exchange rate, 2015-19
LIST OF FIGURES
Figure 1: United States biotechnology industry value: $ billion, 2015-19
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2019
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: United States biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2019
Figure 1: United States biotechnology industry value: $ billion, 2015-19
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2019
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: United States biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2019
